speb/financial-data huggingface dataset:
Financial ratios for STIM — annual report dated 2023-12-31
Total revenue: 71348000
Gross profit: 51705000
Operating income: -30554000
Net income: -30165000
Capital expenditures: 2369000
Operating cash flow: -32038000
Depreciation & amortization: 2006000
Net tangible assets: 34190000
Owner earnings: -30528000
Return on net tangible assets (%): -89.28926586721263
Buffett classification: The Gruesome
Stock price: 2.9
Shares outstanding: 69587840
Book value: 34190000
P/B ratio: 5.902449137174612
Market cap (USD): 201804736
Debt to equity: 1.8272594325826266
Current ratio: 4.734151019584091
Quick ratio: 4.325661215424995
Interest coverage ratio: -6.3654166666666665
COGS to revenue (%): 27.531255255928688
R&D to revenue (%): 13.336043056567808
SG&A to revenue (%): 101.95660705275552
Free cash flow (dilution-adjusted): -41726000
Buyback yield (%): 0
Retained earnings: -376081000
Inventory turnover: 2.427159273446188
Receivables turnover: 3.9997757596143066
Capitalized R&D asset: 15770120
ROCI (R&D-adjusted, %): -24.44125749148635
Rosenberg metric: 0.21229648671808055
FCF margin (%): -58.48236811122946
Revenue growth (%): 9.41937858479281
Rule of 40 score: -49.06298952643665
Financial ratios for STIM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.76
Shares outstanding: 69587840
Market cap (USD): 52886758.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STIM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.61
Shares outstanding: 69587840
Market cap (USD): 112036422.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STIM — annual report dated 2024-12-31
Total revenue: 74890000
Gross profit: 54161000
Operating income: -34563000
Net income: -43708000
Capital expenditures: 1466000
Operating cash flow: -30997000
Depreciation & amortization: 2073000
Net tangible assets: -10534000
Owner earnings: -43101000
Buffett classification: The Gruesome
Stock price: 1.61
Shares outstanding: 69587840
Book value: 31799000
P/B ratio: 3.5232687317211235
Market cap (USD): 112036422.4
Debt to equity: 2.5984464920280512
Current ratio: 1.8590116743962897
Quick ratio: 1.7231408923716616
Interest coverage ratio: -5.317384615384616
COGS to revenue (%): 27.67926291894779
R&D to revenue (%): 17.053011082921618
SG&A to revenue (%): 101.41941514220858
Free cash flow (dilution-adjusted): -38065000
Buyback yield (%): 0
Retained earnings: -419789000
Inventory turnover: 4.879708097928437
Receivables turnover: 3.083796582252419
Capitalized R&D asset: 22226930
ROCI (R&D-adjusted, %): -24.51953424361327
Rosenberg metric: 0.2581187598528639
FCF margin (%): -50.8278808919749
Revenue growth (%): 4.96439984302293
Rule of 40 score: -45.86348104895197
Financial ratios for STIM — quarterly report dated 2025-03-31
Total revenue: 31975000
Gross profit: 15738000
Operating income: -11014000
Net income: -12667000
Capital expenditures: 219000
Operating cash flow: -16993000
Depreciation & amortization: 911000
Net tangible assets: -2424000
Owner earnings: -11975000
Buffett classification: The Gruesome
Stock price: 3.68
Shares outstanding: 69587840
Book value: 39531000
P/B ratio: 6.478036255090941
Market cap (USD): 256083251.20000002
Debt to equity: 2.0879309908679264
Current ratio: 2.4422527273459202
Quick ratio: 2.2784509480294672
Interest coverage ratio: -6.478823529411764
COGS to revenue (%): 50.78029710711493
R&D to revenue (%): 5.053948397185301
SG&A to revenue (%): 78.61141516810008
Free cash flow (dilution-adjusted): -18656000
Buyback yield (%): 0
Retained earnings: -432464000
Inventory turnover: 3.990415335463259
Receivables turnover: 1.189015320541425
Capitalized R&D asset: 1616000
ROCI (R&D-adjusted, %): -8.366803353457446
FCF margin (%): -58.34558248631744
Rule of 40 score: -58.34558248631744
Financial ratios for STIM — quarterly report dated 2025-06-30
Total revenue: 38108000
Gross profit: 17758000
Operating income: -8058000
Net income: -9870000
Capital expenditures: 252000
Operating cash flow: -3504000
Depreciation & amortization: 901000
Net tangible assets: -10810000
Owner earnings: -9221000
Buffett classification: The Gruesome
Stock price: 3.49
Shares outstanding: 69587840
Book value: 31507000
P/B ratio: 7.708177916018663
Market cap (USD): 242861561.60000002
Debt to equity: 2.5599708001396517
Current ratio: 2.019170593101464
Quick ratio: 1.8413840233068375
Interest coverage ratio: -4.476666666666667
COGS to revenue (%): 53.40086071166159
R&D to revenue (%): 4.718169413246563
SG&A to revenue (%): 63.02613624435814
Free cash flow (dilution-adjusted): -5570000
Buyback yield (%): 0
Retained earnings: -442584000
Inventory turnover: 4.116933036617438
Receivables turnover: 1.4303194084750215
Capitalized R&D asset: 2880720
ROCI (R&D-adjusted, %): -6.742143188612686
Rosenberg metric: 1.25
FCF margin (%): -14.616353521570275
Revenue growth (%): 19.18060985144644
Rule of 40 score: 4.564256329876166
Financial ratios for STIM — quarterly report dated 2025-09-30
Total revenue: 37297000
Gross profit: 17108000
Operating income: -7321000
Net income: -9045000
Capital expenditures: 114000
Operating cash flow: -785000
Depreciation & amortization: 886000
Net tangible assets: -13821000
Owner earnings: -8273000
Buffett classification: The Gruesome
Stock price: 2.73
Shares outstanding: 69587840
Book value: 31360000
P/B ratio: 6.05787
Market cap (USD): 189974803.2
Debt to equity: 2.893781887755102
Current ratio: 2.242156185210781
Quick ratio: 2.0928127159640635
Interest coverage ratio: -3.6605
COGS to revenue (%): 54.13035901010805
R&D to revenue (%): 4.032495911199292
SG&A to revenue (%): 61.46606965707697
Free cash flow (dilution-adjusted): -2308000
Buyback yield (%): 0
Retained earnings: -451629000
Inventory turnover: 4.67121702915317
Receivables turnover: 1.94396956113833
Capitalized R&D asset: 3241940
ROCI (R&D-adjusted, %): -6.225702462911162
Rosenberg metric: -0.3615127919911012
FCF margin (%): -6.1881652679840204
Revenue growth (%): -2.1281620657079876
Rule of 40 score: -8.316327333692008
Financial ratios for STIM — annual report dated 2025-12-31
Total revenue: 149157000
Gross profit: 72308000
Operating income: -31436000
Net income: -38998000
Capital expenditures: 801000
Operating cash flow: -20374000
Depreciation & amortization: 3465000
Net tangible assets: -19393000
Owner earnings: -36334000
Buffett classification: The Gruesome
Stock price: 1.38
Shares outstanding: 69587840
Book value: 26240000
P/B ratio: 3.6597263414634145
Market cap (USD): 96031219.19999999
Debt to equity: 3.4414253048780488
Current ratio: 2.0166770420366307
Quick ratio: 1.8749058025621703
Interest coverage ratio: -4.136315789473684
COGS to revenue (%): 51.522221551787716
R&D to revenue (%): 4.4141408046554975
SG&A to revenue (%): 65.13941685606441
Free cash flow (dilution-adjusted): -28023000
Buyback yield (%): 1.8025388143775647
Retained earnings: -458787000
Inventory turnover: 17.760342038363763
Receivables turnover: 8.829515183803942
Capitalized R&D asset: 18280520
ROCI (R&D-adjusted, %): -26.660888327827724
Rosenberg metric: 1.4209537232793046
FCF margin (%): -18.78758623463867
Revenue growth (%): 99.16811323274135
Rule of 40 score: 80.38052699810268
Financial ratios for STIM — quarterly report dated 2025-12-31
Total revenue: 41777000
Gross profit: 21704000
Operating income: -5043000
Net income: -7158000
Capital expenditures: 216000
Operating cash flow: 908000
Depreciation & amortization: 767000
Net tangible assets: -19393000
Owner earnings: -6607000
Buffett classification: The Gruesome
Stock price: 1.38
Shares outstanding: 69587840
Book value: 26240000
P/B ratio: 3.6597263414634145
Market cap (USD): 96031219.19999999
Debt to equity: 3.4414253048780488
Current ratio: 2.0166770420366307
Quick ratio: 1.8749058025621703
Interest coverage ratio: -2.4014285714285712
COGS to revenue (%): 48.047968978145875
R&D to revenue (%): 3.987840199152644
SG&A to revenue (%): 60.035426191445055
Free cash flow (dilution-adjusted): -1489000
Buyback yield (%): 0
Retained earnings: -458787000
Inventory turnover: 4.639010862029119
Receivables turnover: 2.473036168827325
Capitalized R&D asset: 3267020
ROCI (R&D-adjusted, %): -4.403439389758368
Rosenberg metric: 3.0558510638297873
FCF margin (%): -3.5641620987624774
Revenue growth (%): 12.011689948253212
Rule of 40 score: 8.447527849490735
Financial ratios for SURYALAXMI.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.039825926414348
Shares outstanding: 18805290
Market cap (USD): 19554228.09574047
Buyback yield (%): 0
Retained earnings: 10662640.116049057
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SURYALAXMI.NS — annual report dated 2023-03-31
Total revenue: 101278635.80998783
Gross profit: 27811388.550548114
Operating income: 5605858.708891596
Net income: 1266881.851400731
Capital expenditures: 540669.9147381242
Operating cash flow: 12096735.68818514
Depreciation & amortization: 2139074.299634592
Net tangible assets: 32016662.606577348
Owner earnings: 2865286.2362971986
Return on net tangible assets (%): 8.949359499164563
Capex to operating income (%): 9.644729609052648
Buffett classification: The Great
Stock price: 0.5706455542021925
P/E ratio: 8.47052558383248
Shares outstanding: 18805290
Book value: 32037771.010962248
P/B ratio: 0.33495323786137027
Market cap (USD): 10731155.133982949
Debt to equity: 0.7274106651672184
Current ratio: 1.3334542965871805
Quick ratio: 0.8162242769111046
Effective tax rate (%): 31.982569641234033
Interest coverage ratio: 2.8112844507427677
COGS to revenue (%): 72.53972831671432
SG&A to revenue (%): 2.6933451160893305
Free cash flow (dilution-adjusted): 9082496.95493301
Buyback yield (%): 0
Retained earnings: 11115213.154689403
Inventory turnover: 4.022649348917085
Receivables turnover: 5.957528395962195
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.638532281406095
FCF margin (%): 8.967831055675928
Rule of 40 score: 8.967831055675928
Financial ratios for SURYALAXMI.NS — annual report dated 2024-03-31
Total revenue: 91343398.48902746
Gross profit: 26558172.44273894
Operating income: 4551193.18863173
Net income: 432605.8280369349
Capital expenditures: 3902422.352800096
Operating cash flow: 2327041.6117040413
Depreciation & amortization: 2166350.8814006476
Net tangible assets: 31882348.003357716
Owner earnings: -1303465.6433625133
Return on net tangible assets (%): -4.088361507205296
Capex to operating income (%): 85.74503852193801
Buffett classification: The Gruesome
Stock price: 0.7839491362763915
P/E ratio: 34.078114295927584
Shares outstanding: 18805290
Book value: 31904544.909461573
P/B ratio: 0.4620780799338428
Market cap (USD): 14742390.852927063
Debt to equity: 0.8241715905161395
Current ratio: 1.254770587545655
Quick ratio: 0.7205960784931148
Effective tax rate (%): 42.04074419202468
Interest coverage ratio: 2.004754056795132
COGS to revenue (%): 70.92491314965775
SG&A to revenue (%): 2.6499627287247187
Free cash flow (dilution-adjusted): -1674673.222208898
Buyback yield (%): 0
Retained earnings: 11375872.4067634
Inventory turnover: 2.8434238940787173
Receivables turnover: 4.2430396528530165
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.195261155448959
FCF margin (%): -1.8333817768013818
Revenue growth (%): -9.809805633243517
Rule of 40 score: -11.643187410044899
Financial ratios for SURYALAXMI.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 31731318.68131868
Buffett classification: The Gruesome
Stock price: 1.1169374104156713
Shares outstanding: 18805290
Book value: 31753428.093645483
P/B ratio: 0.6614823398837721
Market cap (USD): 21004331.91471572
Debt to equity: 0.9863368789537454
Current ratio: 1.2559348177120093
Quick ratio: 0.649200198315011
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SURYALAXMI.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.0023312740412633
Shares outstanding: 18805290
Market cap (USD): 18849130.284415428
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SURYALAXMI.NS — quarterly report dated 2025-03-31
Total revenue: 28801554.82815057
Gross profit: 9372363.806406358
Operating income: 1215934.0659340657
Net income: 329635.2583586626
Capital expenditures: 0
Depreciation & amortization: 504489.12789338315
Net tangible assets: 31506710.310965627
Owner earnings: 834124.3862520457
Return on net tangible assets (%): 2.64744994961196
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6427821216011204
P/E ratio: 9.167484285291623
Shares outstanding: 18805290
Book value: 31527647.884030856
P/B ratio: 0.3834001270246013
Market cap (USD): 12087704.203524332
Debt to equity: 1.0247000695249133
Current ratio: 1.2726726301148295
Quick ratio: 0.7030441381982054
Effective tax rate (%): 35.079317569589946
Interest coverage ratio: 1.2227956736421348
COGS to revenue (%): 67.45882691983755
Buyback yield (%): 0
Retained earnings: 11514683.189151274
Inventory turnover: 0.7982268701361762
Receivables turnover: 1.3751779894269676
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7124546657240147
Rule of 40 score: 0
Financial ratios for SURYALAXMI.NS — annual report dated 2025-03-31
Total revenue: 92560743.51180734
Gross profit: 35045908.346972175
Operating income: 4050070.1426233337
Net income: 424736.9651624971
Capital expenditures: 2305541.2672433946
Operating cash flow: 907142.857142857
Depreciation & amortization: 2128045.3588964227
Net tangible assets: 31506710.310965627
Owner earnings: 247241.05681552505
Return on net tangible assets (%): 0.7847250772146624
Capex to operating income (%): 56.92595896005981
Buffett classification: The Good
Stock price: 0.6427821216011204
P/E ratio: 28.459270548537692
Shares outstanding: 18805290
Book value: 31527647.884030856
P/B ratio: 0.3834001270246013
Market cap (USD): 12087704.203524332
Debt to equity: 1.0247000695249133
Current ratio: 1.2726726301148295
Quick ratio: 0.7030441381982054
Effective tax rate (%): 34.209763870780826
Interest coverage ratio: 1.0117103199750024
COGS to revenue (%): 62.13739538241543
SG&A to revenue (%): 2.9388280304524854
Free cash flow (dilution-adjusted): -1593277.9985971474
Buyback yield (%): 0
Retained earnings: 11514683.189151274
Inventory turnover: 2.362933526601511
Receivables turnover: 4.419466168473028
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.03472644006331
FCF margin (%): -1.7213323252896127
Revenue growth (%): 1.332712645814371
Rule of 40 score: -0.3886196794752417
Financial ratios for SURYALAXMI.NS — quarterly report dated 2025-06-30
Total revenue: 20868897.729932133
Gross profit: 9141200.561666278
Operating income: 1035431.7809501522
Net income: 170875.26328106716
Capital expenditures: 0
Depreciation & amortization: 568733.9106014511
Owner earnings: 739609.1738825182
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.856541071846478
P/E ratio: 32.18214714091091
Shares outstanding: 18805290
Market cap (USD): 16107503.252983853
Effective tax rate (%): 32.20519962859796
Interest coverage ratio: 1.1876786792832696
COGS to revenue (%): 56.19701299050832
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -27.542461320404403
Rule of 40 score: -27.542461320404403
Financial ratios for SURYALAXMI.NS — quarterly report dated 2025-09-30
Total revenue: 21676009.01916573
Gross profit: 8536200.67643743
Operating income: 569267.1927846674
Net income: 34825.25366403608
Capital expenditures: 0
Depreciation & amortization: 558196.166854566
Net tangible assets: 30557091.319052987
Owner earnings: 593021.420518602
Return on net tangible assets (%): 1.9406998340474924
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.703607666290868
P/E ratio: 24.716349665431974
Shares outstanding: 18805290
Book value: 30577012.401352882
P/B ratio: 0.43272854905332625
Market cap (USD): 13231546.210822998
Debt to equity: 0.9632052580561545
Current ratio: 1.3132088796956378
Quick ratio: 0.6582301185683153
Effective tax rate (%): 33.167459974037214
Interest coverage ratio: 0.741522872457596
COGS to revenue (%): 60.61913118374419
Buyback yield (%): 0
Inventory turnover: 0.5258223439339869
Receivables turnover: 1.2057656138977786
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3237879936251375
Revenue growth (%): 3.8675319591794266
Rule of 40 score: 3.8675319591794266
Financial ratios for SURYALAXMI.NS — quarterly report dated 2025-12-31
Total revenue: 20451732.20452267
Gross profit: 7749069.845159853
Operating income: 192770.41327837808
Net income: 58059.48535145372
Capital expenditures: 0
Depreciation & amortization: 546329.5087445695
Owner earnings: 604388.9940960233
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.661356800712933
P/E ratio: 20.959059256971695
Shares outstanding: 18805290
Market cap (USD): 12437006.430878911
Effective tax rate (%): 26.890166923832236
Interest coverage ratio: 0.2504305292253368
COGS to revenue (%): 62.11044733195639
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -5.648073008091871
Rule of 40 score: -5.648073008091871
Financial ratios for SYNX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1519726.0273972603
Buffett classification: The Gruesome
Stock price: 3.62
Shares outstanding: 6634440
Book value: 1519726.0273972605
P/B ratio: 15.80329109789075
Market cap (USD): 24016672.8
Debt to equity: 0.1636920858121507
Current ratio: 3.187838400666389
Quick ratio: 1.8904623073719284
Buyback yield (%): 0
Retained earnings: -6197260.273972603
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SYNX — annual report dated 2024-12-31
Total revenue: 2491506.8493150687
Gross profit: 1042191.7808219178
Operating income: -402739.72602739726
Net income: -643013.698630137
Capital expenditures: 30684.931506849316
Operating cash flow: -262465.75342465757
Depreciation & amortization: 38082.19178082192
Net tangible assets: 1519726.0273972603
Owner earnings: -635616.4383561645
Return on net tangible assets (%): -41.82440959076979
Buffett classification: The Gruesome
Stock price: 3.62
Shares outstanding: 6634440
Book value: 1519726.0273972605
P/B ratio: 15.80329109789075
Market cap (USD): 24016672.8
Debt to equity: 0.1636920858121507
Current ratio: 3.187838400666389
Quick ratio: 1.8904623073719284
Interest coverage ratio: -30.624999999999996
COGS to revenue (%): 58.17022212447767
R&D to revenue (%): 6.344842753463821
SG&A to revenue (%): 50.90169342423576
Free cash flow (dilution-adjusted): -528767.1232876712
Buyback yield (%): 0
Retained earnings: -6197260.273972603
Inventory turnover: 1.6982343499197432
Receivables turnover: 7.9493006993007
Capitalized R&D asset: 393205.2926095512
ROCI (R&D-adjusted, %): -20.31001791895655
Rosenberg metric: 0.5760822963505176
FCF margin (%): -21.222784253353858
Revenue growth (%): 18.161336231108997
Rule of 40 score: -3.0614480222448606
Financial ratios for SYNX — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1948082.5958702064
Buffett classification: The Gruesome
Stock price: 1.72
Shares outstanding: 6634440
Book value: 1948082.5958702066
P/B ratio: 5.857676067837674
Market cap (USD): 11411236.8
Debt to equity: 0.16262870987280434
Current ratio: 4.309932397295892
Quick ratio: 2.5631825273010924
Buyback yield (%): 0
Retained earnings: -7155162.241887906
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THO — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 106.41
Shares outstanding: 52057373
Market cap (USD): 5539425060.929999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THO — annual report dated 2022-07-31
Total revenue: 16312525000
Gross profit: 2806030000
Operating income: 1532622000
Net income: 1138243000
Capital expenditures: 226290000
Operating cash flow: 990116000
Depreciation & amortization: 284453000
Net tangible assets: 671219000
Owner earnings: 1196406000
Return on net tangible assets (%): 178.24376246798735
Capex to operating income (%): 14.764893104757729
Buffett classification: The Great
Stock price: 77.29
P/E ratio: 3.5348465654258368
Shares outstanding: 52057373
Book value: 3600654000
P/B ratio: 1.1174398759697544
Market cap (USD): 4023514359.1700006
Debt to equity: 0.4908633264956866
Current ratio: 1.7440919725089354
Quick ratio: 0.7447429148091367
Effective tax rate (%): 22.03088780872739
Interest coverage ratio: 17.01174355103672
COGS to revenue (%): 82.79830988764768
SG&A to revenue (%): 6.844201005055931
Free cash flow (dilution-adjusted): 716338000
Buyback yield (%): 4.103551901677802
Retained earnings: 3813261000
Inventory turnover: 7.697004113922428
Receivables turnover: 17.276904534194184
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.115418094425266
FCF margin (%): 4.391337331283784
Rule of 40 score: 4.391337331283784
Financial ratios for THO — annual report dated 2023-07-31
Total revenue: 11121605000
Gross profit: 1596353000
Operating income: 585491000
Net income: 374271000
Capital expenditures: 194539000
Operating cash flow: 981633000
Depreciation & amortization: 276928000
Net tangible assets: 1178614000
Owner earnings: 456660000
Return on net tangible assets (%): 38.745509556139666
Capex to operating income (%): 33.22664225410809
Buffett classification: The Good
Stock price: 108.2
P/E ratio: 15.049543669159512
Shares outstanding: 52057373
Book value: 3983398000
P/B ratio: 1.4140208331178556
Market cap (USD): 5632607758.6
Debt to equity: 0.32702707587843344
Current ratio: 1.6275032304445953
Quick ratio: 0.6644462336336763
Effective tax rate (%): 25.055021197429472
Interest coverage ratio: 6.008301948751629
COGS to revenue (%): 85.64637927709175
SG&A to revenue (%): 7.82309747558918
Free cash flow (dilution-adjusted): 733927000
Buyback yield (%): 0.7457824474971244
Retained earnings: 4091563000
Inventory turnover: 5.762158892242918
Receivables turnover: 17.290541790587653
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.560141607272849
FCF margin (%): 6.599110470116498
Revenue growth (%): -31.821683031903397
Rule of 40 score: -25.222572561786897
Financial ratios for THO — annual report dated 2024-07-31
Total revenue: 10043408000
Gross profit: 1451962000
Operating income: 423887000
Net income: 265400000
Capital expenditures: 114708000
Operating cash flow: 545548000
Depreciation & amortization: 277145000
Net tangible assets: 1419324000
Owner earnings: 427837000
Return on net tangible assets (%): 30.143716304381524
Capex to operating income (%): 27.060985592858472
Buffett classification: The Good
Stock price: 101.34
P/E ratio: 19.877521400979653
Shares outstanding: 52057373
Book value: 4074053000
P/B ratio: 1.2949007241241093
Market cap (USD): 5275494179.820001
Debt to equity: 0.27832603061374017
Current ratio: 1.6911230346478863
Quick ratio: 0.8189987122069761
Effective tax rate (%): 23.920147687791676
Interest coverage ratio: 4.780716396363882
COGS to revenue (%): 85.54313436235987
SG&A to revenue (%): 8.916604801876018
Free cash flow (dilution-adjusted): 368012000
Buyback yield (%): 1.2963145758286734
Retained earnings: 4254734000
Inventory turnover: 6.2865557667794985
Receivables turnover: 14.329404547043422
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.772322459143632
FCF margin (%): 3.6642143782269923
Revenue growth (%): -9.694616919050802
Rule of 40 score: -6.030402540823809
Financial ratios for THO — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 99.38
Shares outstanding: 52057373
Market cap (USD): 5173461728.74
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THO — quarterly report dated 2025-01-31
Total revenue: 2018107000
Gross profit: 245197000
Operating income: 9731000
Net income: -551000
Capital expenditures: 8419000
Operating cash flow: 30842000
Depreciation & amortization: 65994000
Net tangible assets: 1413333000
Owner earnings: 57024000
Capex to operating income (%): 86.51731579488234
Buffett classification: The Gruesome
Stock price: 99.18
Shares outstanding: 52057373
Book value: 3953495000
P/B ratio: 1.3059458160791908
Market cap (USD): 5163050254.14
Debt to equity: 0.2608165686310467
Current ratio: 1.712210185622277
Quick ratio: 0.7766252122908969
Interest coverage ratio: 0.8143096234309624
COGS to revenue (%): 87.85014867893526
SG&A to revenue (%): 10.218586031365037
Free cash flow (dilution-adjusted): -3496000
Buyback yield (%): 0.03341048246851376
Retained earnings: 4199198000
Inventory turnover: 1.2852585037613662
Receivables turnover: 3.0891063496291125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.18571535719622675
FCF margin (%): -0.17323164728133839
Rule of 40 score: -0.17323164728133839
Financial ratios for THO — quarterly report dated 2025-04-30
Total revenue: 2894816000
Gross profit: 443119000
Operating income: 175242000
Net income: 135185000
Capital expenditures: 32628000
Operating cash flow: 257667000
Depreciation & amortization: 66173000
Net tangible assets: 1601923000
Owner earnings: 168730000
Return on net tangible assets (%): 10.532965691859097
Capex to operating income (%): 18.618824254459547
Buffett classification: The Great
Stock price: 70.34
P/E ratio: 6.7716751429892375
Shares outstanding: 52057373
Book value: 4224131000
P/B ratio: 0.8668565479669074
Market cap (USD): 3661715616.82
Debt to equity: 0.24054580693638525
Current ratio: 1.7133646706261216
Quick ratio: 0.895547123756125
Effective tax rate (%): 13.91695590692891
Interest coverage ratio: 15.63962516733601
COGS to revenue (%): 84.69267131313354
SG&A to revenue (%): 8.231024009816167
Free cash flow (dilution-adjusted): 215967000
Buyback yield (%): 0
Retained earnings: 4307781000
Inventory turnover: 1.8112713120337358
Receivables turnover: 3.38209072056547
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.17744842416748
FCF margin (%): 7.460474171760831
Revenue growth (%): 43.44214652642303
Rule of 40 score: 50.90262069818386
Financial ratios for THO — quarterly report dated 2025-07-31
Total revenue: 2523783000
Gross profit: 370883000
Operating income: 102664000
Net income: 126625000
Capital expenditures: 3275000
Operating cash flow: 258674000
Depreciation & amortization: 71379000
Net tangible assets: 1688622000
Owner earnings: 194729000
Return on net tangible assets (%): 11.53182891138455
Capex to operating income (%): 3.190017922543443
Buffett classification: The Great
Stock price: 88.88
P/E ratio: 17.709856166639234
Shares outstanding: 52057373
Book value: 4289552000
P/B ratio: 1.0786346248372791
Market cap (USD): 4626859312.24
Debt to equity: 0.21516908991894726
Current ratio: 1.7530018375764185
Quick ratio: 0.8999700889003317
Effective tax rate (%): 11.677722209434528
Interest coverage ratio: 10.207198250149135
COGS to revenue (%): 85.30448140747441
SG&A to revenue (%): 9.42481980423832
Free cash flow (dilution-adjusted): 216663000
Buyback yield (%): 1.1005737707496264
Retained earnings: 4407163000
Inventory turnover: 1.5926219636690744
Receivables turnover: 3.5678753341636473
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.873229660759028
FCF margin (%): 8.58485059927894
Revenue growth (%): -12.817153145484895
Rule of 40 score: -4.232302546205954
Financial ratios for THO — annual report dated 2025-07-31
Total revenue: 9579490000
Gross profit: 1340641000
Operating income: 299060000
Net income: 258559000
Capital expenditures: 59682000
Operating cash flow: 577923000
Depreciation & amortization: 271207000
Net tangible assets: 1688622000
Owner earnings: 470084000
Return on net tangible assets (%): 27.838320239816845
Capex to operating income (%): 19.956530462114625
Buffett classification: The Great
Stock price: 88.88
P/E ratio: 17.894791178183702
Shares outstanding: 52057373
Book value: 4289552000
P/B ratio: 1.0786346248372791
Market cap (USD): 4626859312.24
Debt to equity: 0.21516908991894726
Current ratio: 1.7530018375764185
Quick ratio: 0.8999700889003317
Effective tax rate (%): 13.369751275359482
Interest coverage ratio: 6.173695836171838
COGS to revenue (%): 86.00509004132788
SG&A to revenue (%): 9.630512689088878
Free cash flow (dilution-adjusted): 424064000
Buyback yield (%): 1.1378560800568631
Retained earnings: 4407163000
Inventory turnover: 6.094742845814014
Receivables turnover: 13.542537565578069
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.456713768668617
FCF margin (%): 4.4267909878292055
Revenue growth (%): -4.619129283605725
Rule of 40 score: -0.19233829577651917
Financial ratios for THO — quarterly report dated 2025-10-31
Total revenue: 2389123000
Gross profit: 320974000
Operating income: 39016000
Net income: 23169000
Capital expenditures: 20676000
Operating cash flow: -44867000
Depreciation & amortization: 66035000
Net tangible assets: 1712080000
Owner earnings: 68528000
Return on net tangible assets (%): 4.002616700154198
Capex to operating income (%): 52.99364363338118
Buffett classification: The Good
Stock price: 102.42
P/E ratio: 18.745398282377263
Shares outstanding: 52057373
Book value: 4299273000
P/B ratio: 1.2401436574648783
Market cap (USD): 5331716142.66
Debt to equity: 0.2130499737978956
Current ratio: 1.8069177321860026
Quick ratio: 0.8342918412453141
Effective tax rate (%): 28.684437330706725
Interest coverage ratio: 4.326938005988688
COGS to revenue (%): 86.56519568059075
SG&A to revenue (%): 10.632771941838072
Free cash flow (dilution-adjusted): -87398000
Buyback yield (%): 0.09465995309874178
Retained earnings: 4401356000
Inventory turnover: 1.4125880669496649
Receivables turnover: 3.6439444086864476
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.711179810047037
FCF margin (%): -3.658162430314387
Revenue growth (%): -5.335640980226906
Rule of 40 score: -8.993803410541293
Financial ratios for THO — quarterly report dated 2026-01-31
Total revenue: 2125856000
Gross profit: 251254000
Operating income: 11436000
Net income: 17803000
Capital expenditures: 10448000
Operating cash flow: -112241000
Depreciation & amortization: 64878000
Net tangible assets: 1725578000
Owner earnings: 72233000
Return on net tangible assets (%): 4.186017670600807
Capex to operating income (%): 91.3606155998601
Buffett classification: The Gruesome
Stock price: 110.35
P/E ratio: 18.972498730274587
Shares outstanding: 52057373
Book value: 4322713000
P/B ratio: 1.3289179990783566
Market cap (USD): 5744531110.549999
Debt to equity: 0.20373570949540254
Current ratio: 1.7637420255507037
Quick ratio: 0.7326078275408665
Effective tax rate (%): 30.25438262195122
Interest coverage ratio: 1.2140127388535031
COGS to revenue (%): 88.1810433067903
SG&A to revenue (%): 9.973441286709917
Free cash flow (dilution-adjusted): -148626000
Buyback yield (%): 0.4392525606425711
Retained earnings: 4391808000
Inventory turnover: 1.1804620081308594
Receivables turnover: 2.7700867697896756
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.20880909250757698
FCF margin (%): -6.99134842623395
Revenue growth (%): -11.019399168648915
Rule of 40 score: -18.010747594882865
Financial ratios for THS.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.010810810810810811
Shares outstanding: 296290377
Market cap (USD): 3203139.210810811
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THS.L — annual report dated 2022-09-30
Total revenue: 672545098.0392157
Gross profit: 240843137.25490195
Operating income: 191165686.2745098
Net income: 163878431.37254903
Capital expenditures: 101261764.70588236
Operating cash flow: 170270588.2352941
Depreciation & amortization: 38035294.11764706
Net tangible assets: 547143137.254902
Owner earnings: 100651960.78431372
Return on net tangible assets (%): 18.395910307730347
Capex to operating income (%): 52.97068039735575
Buffett classification: The Good
Stock price: 0.009777777777777778
P/E ratio: 0.017678113219268227
Shares outstanding: 296290377
Book value: 608216666.6666667
P/B ratio: 0.00476320630915518
Market cap (USD): 2897061.464
Debt to equity: 0.10136351693556055
Current ratio: 2.2305042875127676
Quick ratio: 1.795577092092449
Effective tax rate (%): 24.096938103649485
Interest coverage ratio: 40.98129466162253
COGS to revenue (%): 64.18929556440563
R&D to revenue (%): 0.10087522376223768
SG&A to revenue (%): 2.0138601391261757
Free cash flow (dilution-adjusted): 65640196.07843137
Buyback yield (%): 0
Retained earnings: 351375490.1960784
Inventory turnover: 6.012233752048061
Receivables turnover: 5.209766470476552
Capitalized R&D asset: 678431.3725490196
ROCI (R&D-adjusted, %): 24.878577389915606
FCF margin (%): 9.75996944588598
Rule of 40 score: 9.75996944588598
Financial ratios for THS.L — annual report dated 2023-09-30
Total revenue: 684097894.7368422
Gross profit: 161401052.63157895
Operating income: 104483157.89473684
Net income: 91343157.89473684
Capital expenditures: 73426315.78947368
Operating cash flow: 156072631.57894737
Depreciation & amortization: 41306315.78947368
Net tangible assets: 646651578.9473685
Owner earnings: 59223157.89473684
Return on net tangible assets (%): 9.158433973228892
Capex to operating income (%): 70.27574325753835
Buffett classification: The Good
Stock price: 0.007804878048780489
P/E ratio: 0.02531673212105404
Shares outstanding: 296290377
Book value: 710711578.9473684
P/B ratio: 0.003253795671849393
Market cap (USD): 2312510.2595121954
Debt to equity: 0.20684384516037302
Current ratio: 2.1983079983775324
Quick ratio: 1.7633322388117354
Effective tax rate (%): 24.107049151652966
Interest coverage ratio: 13.978172088438246
COGS to revenue (%): 76.40673156965838
R&D to revenue (%): 0.19187773987410234
SG&A to revenue (%): 2.6098142309580195
Free cash flow (dilution-adjusted): 79723157.89473684
Buyback yield (%): 0
Retained earnings: 450195789.47368425
Inventory turnover: 5.512455595026643
Receivables turnover: 9.927486863008678
Capitalized R&D asset: 1767180.5985552117
ROCI (R&D-adjusted, %): 11.315659309803571
Rosenberg metric: -117.09671432917551
FCF margin (%): 11.653764542778578
Revenue growth (%): 1.7177727904505276
Rule of 40 score: 13.371537333229107
Financial ratios for THS.L — annual report dated 2024-09-30
Total revenue: 801548888.8888888
Gross profit: 205121111.1111111
Operating income: 132787777.77777778
Net income: 92105555.55555555
Capital expenditures: 214517777.77777776
Operating cash flow: 227276666.66666666
Depreciation & amortization: 60807777.777777776
Net tangible assets: 794442222.2222222
Owner earnings: -61604444.44444445
Return on net tangible assets (%): -7.754427285111287
Capex to operating income (%): 161.5493393802977
Buffett classification: The Gruesome
Stock price: 0.0096
P/E ratio: 0.03088182468520417
Shares outstanding: 296290377
Book value: 866202222.2222221
P/B ratio: 0.003283745465236499
Market cap (USD): 2844387.6191999996
Debt to equity: 0.13620504321546675
Current ratio: 1.8379117379435852
Quick ratio: 1.4632347588717016
Effective tax rate (%): 29.773366530986838
Interest coverage ratio: 10.061373968681595
COGS to revenue (%): 74.4094073418964
R&D to revenue (%): 0.14250187830783181
SG&A to revenue (%): 2.709476374907471
Free cash flow (dilution-adjusted): -533333.333333333
Buyback yield (%): 195.35546523822626
Retained earnings: 562592222.2222222
Inventory turnover: 6.518019768317265
Receivables turnover: 11.897320029685824
Capitalized R&D asset: 2245567.7330581355
ROCI (R&D-adjusted, %): 12.080225724444945
Rosenberg metric: 33.307181680477576
FCF margin (%): -0.06653784201143893
Revenue growth (%): 17.16874076877953
Rule of 40 score: 17.10220292676809
Financial ratios for THS.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 794442222.2222222
Buffett classification: The Gruesome
Stock price: 0.0096
Shares outstanding: 296290377
Book value: 866202222.2222221
P/B ratio: 0.003283745465236499
Market cap (USD): 2844387.6191999996
Debt to equity: 0.13620504321546675
Current ratio: 1.8379117379435852
Quick ratio: 1.4632347588717016
Buyback yield (%): 0
Retained earnings: 562592222.2222222
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THS.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 750152173.9130435
Buffett classification: The Gruesome
Stock price: 0.007792207792207792
Shares outstanding: 296290377
Book value: 819473913.0434783
P/B ratio: 0.0028173638570640996
Market cap (USD): 2308756.1844155844
Debt to equity: 0.14068410804386694
Current ratio: 1.6646035928143712
Quick ratio: 1.4154826347305387
Buyback yield (%): 0
Retained earnings: 545342391.3043478
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THS.L — annual report dated 2025-09-30
Total revenue: 788495294.117647
Gross profit: 225075294.11764705
Operating income: 147598823.52941176
Net income: 95116470.5882353
Capital expenditures: 133309411.76470588
Operating cash flow: 110541176.47058824
Depreciation & amortization: 76484705.88235295
Net tangible assets: 914617647.0588236
Owner earnings: 38291764.705882385
Return on net tangible assets (%): 4.186641798244207
Capex to operating income (%): 90.31874955164636
Buffett classification: The Gruesome
Stock price: 0.013648648648648648
P/E ratio: 0.04251590948065345
Shares outstanding: 296290377
Book value: 997461176.4705882
P/B ratio: 0.0040542562949244685
Market cap (USD): 4043963.2536486485
Debt to equity: 0.12425192429721577
Current ratio: 2.029422288725522
Quick ratio: 1.6507221390930973
Effective tax rate (%): 31.232722911651884
Interest coverage ratio: 12.639431795285109
COGS to revenue (%): 71.45508720257945
R&D to revenue (%): 0.05072953548157995
SG&A to revenue (%): 2.718207874715952
Free cash flow (dilution-adjusted): -35072941.17647059
Buyback yield (%): 107.34955285934973
Retained earnings: 673692941.1764706
Inventory turnover: 6.856024165378228
Receivables turnover: 8.262500616401203
Capitalized R&D asset: 1598457.3099415207
ROCI (R&D-adjusted, %): 11.847610825241969
Rosenberg metric: 17.469615472648204
FCF margin (%): -4.448085034637829
Revenue growth (%): -1.6285462998191842
Rule of 40 score: -6.076631334457014
Financial ratios for THS.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 914617647.0588236
Buffett classification: The Gruesome
Stock price: 0.013648648648648648
Shares outstanding: 296290377
Book value: 997461176.4705882
P/B ratio: 0.0040542562949244685
Market cap (USD): 4043963.2536486485
Debt to equity: 0.12425192429721577
Current ratio: 2.029422288725522
Quick ratio: 1.6507221390930973
Buyback yield (%): 0
Retained earnings: 673692941.1764706
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TML.AX — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 878657.0743405276
Buffett classification: The Gruesome
Stock price: 0.05072463768115943
Shares outstanding: 88759761
Market cap (USD): 4502306.717391306
Buyback yield (%): 1.203752789131469
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TML.AX — annual report dated 2022-12-31
Total revenue: 2035746.6063348416
Gross profit: 452.4886877828054
Operating income: -949095.0226244344
Net income: -505429.86425339367
Capital expenditures: 177828.05429864253
Depreciation & amortization: 829638.0090497738
Net tangible assets: 5299773.755656108
Owner earnings: 146380.0904977376
Buffett classification: The Gruesome
Stock price: 0.0472972972972973
Shares outstanding: 88759761
Book value: 1170361.9909502259
P/B ratio: 3.587007128149802
Market cap (USD): 4198096.804054054
Debt to equity: 5.341387976029385
Current ratio: 27.80997624703088
Quick ratio: 27.3562945368171
Interest coverage ratio: -3.5793515358361776
COGS to revenue (%): 99.97777283840854
SG&A to revenue (%): 5.890197821738164
Free cash flow (dilution-adjusted): 965837.1040723982
Buyback yield (%): 1.1532914044765503
Retained earnings: -5288235.294117647
Inventory turnover: 47.09947643979058
Receivables turnover: 3.9430324276950044
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.432987639583178
FCF margin (%): 47.44387641698155
Rule of 40 score: 47.44387641698155
Financial ratios for TML.AX — annual report dated 2023-12-31
Total revenue: 1983947.9392624728
Gross profit: 222559.65292841647
Operating income: -683947.9392624728
Net income: 93926.24728850325
Capital expenditures: 258568.32971800433
Depreciation & amortization: 806941.4316702819
Net tangible assets: 4990672.451193058
Owner earnings: 642299.3492407808
Return on net tangible assets (%): 12.869996088147085
Buffett classification: The Gruesome
Stock price: 0.02054794520547945
P/E ratio: 19.41768949713689
Shares outstanding: 88759761
Book value: -161388.2863340564
Market cap (USD): 1823830.705479452
Debt to equity: -30.928763440860212
Current ratio: 11.878787878787879
Quick ratio: 11.672176308539946
Effective tax rate (%): 48.01920768307323
Interest coverage ratio: -2.5844262295081966
COGS to revenue (%): 88.78198119396457
SG&A to revenue (%): 5.018587360594796
Free cash flow (dilution-adjusted): 842950.1084598697
Buyback yield (%): 10.70427014635436
Retained earnings: -4976355.748373101
Inventory turnover: 54.13333333333333
Receivables turnover: 8.1733690795353
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.62617956322459
FCF margin (%): 42.48851957139733
Revenue growth (%): -2.544455528560458
Rule of 40 score: 39.94406404283688
Financial ratios for TML.AX — annual report dated 2024-12-31
Total revenue: 2040358.7443946188
Gross profit: 249103.13901345292
Operating income: -721300.4484304932
Net income: -788565.0224215246
Capital expenditures: 40807.174887892375
Depreciation & amortization: 835874.4394618834
Net tangible assets: 4355381.1659192825
Owner earnings: 6502.242152466388
Buffett classification: The Gruesome
Stock price: 0.024844720496894408
Shares outstanding: 88759761
Book value: 4355381.165919282
P/B ratio: 0.5063188201923309
Market cap (USD): 2205211.453416149
Debt to equity: 1.1553667953667957
Current ratio: 17.199619771863116
Quick ratio: 16.771863117870723
Interest coverage ratio: -2.7170608108108105
COGS to revenue (%): 87.79120879120879
SG&A to revenue (%): 6.593406593406594
Free cash flow (dilution-adjusted): 372421.52466367715
Buyback yield (%): 0
Retained earnings: -5932286.995515695
Inventory turnover: 35.50666666666667
Receivables turnover: 9.859154929577464
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.529460715662994
FCF margin (%): 18.252747252747252
Revenue growth (%): 2.8433611596238033
Rule of 40 score: 21.096108412371056
Financial ratios for TML.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4355381.1659192825
Buffett classification: The Gruesome
Stock price: 0.024844720496894408
Shares outstanding: 88759761
Book value: 4355381.165919282
P/B ratio: 0.5063188201923309
Market cap (USD): 2205211.453416149
Debt to equity: 1.1553667953667957
Current ratio: 17.199619771863116
Quick ratio: 16.771863117870723
Buyback yield (%): 0
Retained earnings: -5932286.995515695
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VTAK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14820
Shares outstanding: 3609471
Market cap (USD): 53492360220
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VTAK — annual report dated 2022-12-31
Total revenue: 14000
Gross profit: -147000
Operating income: -22789000
Net income: -26865000
Capital expenditures: 21000
Operating cash flow: -22568000
Depreciation & amortization: 421000
Net tangible assets: 9260000
Owner earnings: -26465000
Return on net tangible assets (%): -285.79913606911447
Buffett classification: The Gruesome
Stock price: 1119.1
Shares outstanding: 3609471
Book value: 9260000
P/B ratio: 436.21587430885523
Market cap (USD): 4039358996.1
Debt to equity: 0
Current ratio: 2.2222808870116157
Quick ratio: 2.2222808870116157
COGS to revenue (%): 1150
R&D to revenue (%): 45657.142857142855
SG&A to revenue (%): 116071.42857142858
Free cash flow (dilution-adjusted): -23032000
Buyback yield (%): 0
Retained earnings: -205137000
Capitalized R&D asset: 6392000
ROCI (R&D-adjusted, %): -118.37251895391432
FCF margin (%): -164514.2857142857
Rule of 40 score: -164514.2857142857
Financial ratios for VTAK — annual report dated 2023-12-31
Total revenue: 442000
Gross profit: 412000
Operating income: -17185000
Net income: -70572000
Capital expenditures: 76000
Operating cash flow: -20619000
Depreciation & amortization: 2075000
Net tangible assets: -5125000
Owner earnings: -68573000
Buffett classification: The Gruesome
Stock price: 76
Shares outstanding: 3609471
Book value: 21193000
P/B ratio: 12.9438869438022
Market cap (USD): 274319796
Debt to equity: 0.017552965601849668
Current ratio: 1.683252427184466
Quick ratio: 1.6654530744336569
COGS to revenue (%): 6.787330316742081
R&D to revenue (%): 107.46606334841628
SG&A to revenue (%): 3873.7556561085976
Free cash flow (dilution-adjusted): -21912000
Buyback yield (%): 0
Retained earnings: -275709000
Inventory turnover: 0.6818181818181818
Receivables turnover: 3.2262773722627736
Capitalized R&D asset: 4757640
ROCI (R&D-adjusted, %): -57.534998261745926
Rosenberg metric: 0.08745306633291615
FCF margin (%): -4957.466063348416
Revenue growth (%): 3057.1428571428573
Rule of 40 score: -1900.323206205559
Financial ratios for VTAK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.6
Shares outstanding: 3609471
Market cap (USD): 27431979.599999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VTAK — annual report dated 2024-12-31
Total revenue: 420000
Gross profit: 378000
Operating income: -11243000
Net income: -16643000
Capital expenditures: 67000
Operating cash flow: -9271000
Depreciation & amortization: 2109000
Net tangible assets: -12517000
Owner earnings: -14601000
Buffett classification: The Gruesome
Stock price: 8.55
Shares outstanding: 3609471
Book value: 11757000
P/B ratio: 2.624902360295994
Market cap (USD): 30860977.05
Debt to equity: 0.15726801054690823
Current ratio: 1.4762331838565022
Quick ratio: 1.4614349775784754
Interest coverage ratio: -123.54945054945055
COGS to revenue (%): 10
R&D to revenue (%): 64.76190476190476
SG&A to revenue (%): 2702.1428571428573
Free cash flow (dilution-adjusted): -9392000
Buyback yield (%): 0
Retained earnings: -292352000
Inventory turnover: 1.2727272727272727
Receivables turnover: 6
Capitalized R&D asset: 2699610
ROCI (R&D-adjusted, %): -47.276384718721914
Rosenberg metric: -0.07157894736842105
FCF margin (%): -2236.190476190476
Revenue growth (%): -4.97737556561086
Rule of 40 score: -2241.167851756087
Financial ratios for VTAK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.55
Shares outstanding: 3609471
Market cap (USD): 30860977.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VTAK — quarterly report dated 2025-03-31
Total revenue: 143000
Gross profit: 132000
Operating income: -3456000
Net income: -4045000
Capital expenditures: 10000
Operating cash flow: -2338000
Depreciation & amortization: 554000
Net tangible assets: -15847000
Owner earnings: -3501000
Buffett classification: The Gruesome
Stock price: 6.46
Shares outstanding: 3609471
Book value: 7916000
P/B ratio: 2.9455763845376453
Market cap (USD): 23317182.66
Debt to equity: 0.22662961091460335
Current ratio: 0.20885302029836145
Quick ratio: 0.19148936170212766
Interest coverage ratio: -70.53061224489795
COGS to revenue (%): 7.6923076923076925
R&D to revenue (%): 72.02797202797203
SG&A to revenue (%): 2437.062937062937
Free cash flow (dilution-adjusted): -2439000
Buyback yield (%): 0
Retained earnings: -296397000
Inventory turnover: 0.15492957746478872
Receivables turnover: 1.6823529411764706
Capitalized R&D asset: 103000
ROCI (R&D-adjusted, %): -16.274302552768972
FCF margin (%): -1705.5944055944058
Rule of 40 score: -1705.5944055944058